Literature DB >> 30245625

p58IPK Is an Endogenous Neuroprotectant for Retinal Ganglion Cells.

Todd McLaughlin1,2, Narayan Dhimal1, Junhua Li1, Joshua Jianxin Wang1,2, Sarah Xin Zhang1,2.   

Abstract

p58IPK is an endoplasmic reticulum (ER)-resident chaperone playing a critical role in facilitating protein folding and protein homeostasis. Previously, we have demonstrated that p58IPK is expressed broadly in retinal neurons including retinal ganglion cells (RGCs) and loss of p58IPK results in age-related RGC degeneration. In the present study, we investigate the role of p58IPK in neuroprotection by in vitro and in vivo studies using primary RGC culture and two well-established disease-relevant RGC injury models: retinal ischemia/reperfusion (I/R) and microbead-induced ocular hypertension. Our results demonstrate that in both in vivo models, p58IPK -/- mice exhibit significantly increased RGC loss compared to wild type (WT) mice. In vitro, p58IPK-deficient RGCs show reduced viability and are more susceptible to cell death induced by the ER stress inducer tunicamycin (TM). Overexpression of p58IPK by adeno-associated virus (AAV) significantly diminishes TM-induced cell death in both WT and p58IPK -/- RGCs. Interestingly, we find that loss of p58IPK leads to reduced mRNA expression, but not the protein level, of mesencephalic astrocyte-derived neurotrophic factor (MANF), a neurotrophic factor that resides in the ER. Treatment with recombinant MANF protein protects R28 retinal neural cells and mouse retinal explants from TM-induced cell death. Taken together, our study suggests that p58IPK functions as an endogenous neuroprotectant for RGCs. The mechanisms underlying p58IPK's neuroprotective action and the potential interactions between p58IPK and MANF warrant future investigation.

Entities:  

Keywords:  X-box binding protein 1; ocular hypertension; p58IPK; retinal ganglion cells; retinal ischemia/reperfusion

Year:  2018        PMID: 30245625      PMCID: PMC6137320          DOI: 10.3389/fnagi.2018.00267

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.750


Introduction

Accumulating evidence suggests that disturbed protein homeostasis in the endoplasmic reticulum (ER), or ER stress, is a significant contributing factor to neurodegeneration in the central nervous system including the retina (Zhang et al., 2014). Prolonged ER stress activates pro-apoptotic genes such as C/EBP homologous protein (CHOP) resulting in apoptosis, while reducing ER stress alleviates cell death of retinal neurons, such as retinal ganglion cells (RGCs), induced by a variety of disease-provoking insults (Hu et al., 2012; Jing et al., 2012; Chen et al., 2014; Huang et al., 2015). In addition, ER stress reduces the production of neurotrophic factors but increases the secretion of pro-inflammatory cytokines, which further exacerbate neuronal death (Zhong et al., 2012; Kim et al., 2014; Cai et al., 2016). Thus, restoring ER protein homeostasis may provide a new strategy to prevent and treat retinal neurodegeneration. The ER chaperone p58IPK is an important component of the ER protein folding system and is upregulated by the highly conserved unfolded protein response (UPR) genes XBP1 and ATF6 (Lee et al., 2003; van Huizen et al., 2003). Activation of p58IPK facilitates protein folding, reduces ER stress, and promotes cell survival (Rutkowski et al., 2007). In pancreatic β cells, deletion of p58IPK results in CHOP-mediated apoptosis and reduced insulin production (Huber et al., 2013). In a previous study, we demonstrated that p58IPK is present throughout the retina and mice lacking p58IPK display increased susceptibility to retinal injury caused by glutamate toxicity and age-related cell death (Boriushkin et al., 2015). In R28 retinal neural cells, p58IPK overexpression suppresses ER stress and improves cell survival under conditions of oxidative stress (Boriushkin et al., 2015). Furthermore, p58IPK acts as a potent inhibitor of NLRP3 inflammasome and reduces IL-1β secretion in bone marrow macrophages (Boriushkin et al., 2016). These findings suggest that p58IPK may function as a neuroprotectant and play an important role in maintaining the viability of retinal neurons such as RGCs in pathogenic conditions related to ischemic retinopathy and glaucoma. In the present study, we tested this hypothesis in two commonly used RGC injury models induced by retinal ischemia/reperfusion (I/R) or ocular hypertension and explored the potential mechanism of p58IPK neuroprotection and its interaction with mesencephalic astrocyte-derived neurotrophic factor (MANF), an ER stress responsive neurotrophic factor.

Materials and Methods

Animals

The generation and maintenance of p58IPK knockout mice were previously described elsewhere (Ladiges et al., 2005; Boriushkin et al., 2015). All experimental procedures were performed in compliance with protocols approved by the Institutional Animal Care and Use Committees at the State University of New York at Buffalo.

Isolation and Culture of Mouse RGCs

RGCs were isolated from retinas of postnatal day 6 neonatal mice using the Miltenyi Biotec magnetic cell sorting (MACS) system following a published protocol (Huang et al., 2003; Jiao et al., 2005). Immediately after isolation, cells were incubated with adeno-associated virus (AAV)-GFP or AAV-p58IPK (Vector Biolabs, Malvern, PA, USA) at 10∧12 GC/ml following standard procedures approved by the Institutional Biosafety Committee at the University at Buffalo. After 24 h, transduced cells were treated with 1 μg/ml tunicamycin (TM) or a vehicle control (0.05% DMSO) for an additional 16 h. Cell viability was examined using the live/dead cytotoxicity assay (Molecular Probes) following the manufacturer’s protocol. Images were analyzed for live cells (green) and dead cells (red), blind to treatment or genotype (see Supplementary Material).

Retinal Ischemia/Reperfusion (I/R) Mouse Model

The anterior chamber of anesthetized mice was canulated with a 30g needle attached to a reservoir of sterile PBS. Retinal ischemia was induced by elevating the reservoir to generate a hydrostatic pressure of 90 mmHg for 60 min. After 7 days, mice were sacrificed and retinal whole-mounts were prepared for Tuj1 immunostaining to visualize RGCs (see Supplementary Material).

Microbead-Induced Ocular Hypertension Mouse Model

Microbead injection was performed as described previously (Chen et al., 2011). Briefly, the anterior chamber of anesthetized mice was canulated and 2 μl PBS containing 10 μm diameter polystyrene, fluorescent microspheres at 1.5 × 107 beads/ml (FluoSpheres, Invitrogen) was injected. Intraocular pressure (IOP) was recorded by bounce tonometer (Icare). Two weeks after microbead injection mice were sacrificed and retina whole-mounts were prepared for Tuj1 immunostaining (see Supplementary Material).

R28 Cell Treatment and Analysis

R28 cells were cultured as described previously (Boriushkin et al., 2015). At approximately 60%–70% confluence, cells were pretreated with 50 ng/ml recombinant human MANF (hMANF; PeproTech) or vehicle for 16 h and then treated with 5 μg/ml TM or vehicle for 24 h. Cells were labeled using the live/dead cytotoxicity assay, photographed, and analyzed (see Supplementary Material).

Immunohistochemistry and Morphological Analysis

Mouse eye cryosections were prepared for immunohistochemistry as described previously (McLaughlin et al., 2018). The primary antibodies used were: Ribeye (Synaptic Systems 192003, 1:800); PKCα (Santa Cruz sc-8393, 1:400); Pax6 (DSHB Pax6-s, 1:25); and calretinin (Millipore Mab1658, 1:800). The secondary antibodies used were: Texas-red conjugated goat-anti-rabbit (ThermoFisher T6391, 1:800); Alexa594 conjugated goat-anti-mouse (ThermoFisher A11005, 1:800). Photomontages were assembled with Adobe Photoshop.

Quantitative RT-PCR

Total RNA was isolated with Trizol (Invitrogen) per manufacturer instructions. cDNA was made from 500 ng of total RNA using Bio-Rad cDNA kit followed by quantitative RT-PCR (qPCR) with Bio-Rad iQ Sybr Green Supermix. The following primers were used: MANF f1: 5’-CAC CAG CCA CTA TTG AAG AAG A-3’ with MANF r1: 5’-AGC ATC ATC GTG GTC CAA-3’; MANF f2: 5’-AAA GAG AAT CGG TTG TGC TAC T-3’ with MANF r2: 5’-CCA GGA TCT TCT TCA GCT CTT T-3’; 18sF 5’-GTA ACC CGT TGA ACC CCA TT-3’ with 18sR 5’-CCA TCC AAT CGG TAG TAG CG-3’.

Statistical Analysis

The quantitative data were expressed as mean ± SD. Statistical analyses were performed using Student’s t-test for two-group comparisons and one-way ANOVA with Bonferroni post hoc test for three groups or more. Statistical differences were considered significant at a p value of less than 0.05.

Results

p58IPK Deletion Does Not Affect Retinal Morphology in Young Adult Mice

We first examined overall retinal morphology of young adult p58IPK −/− and wild type (WT) mice using a variety of retinal cell type specific markers. We found that there was no significant difference in retinal expression of PKCα, Pax6, ribeye, or calretinin in p58IPK −/− and WT mice (Figure 1A). The retinal layer thickness was identical in these mice (not shown). We conclude that the retinas of p58IPK −/− mice were morphologically indistinguishable from WT at the ages we performed the retinal injury interventions described below.
Figure 1

Loss of p58IPK exacerbates retinal ganglion cell (RGC) cell death in retinal ischemia/reperfusion (I/R) and microbead-induced ocular hypertension. (A) Retinal cryosections (20 μM) from 2-month-old wild type (WT) and p58IPK −/− mice labeled with primary antibodies against various retinal markers and a fluorescent secondary antibody (red). Anti-Pax6 labels amacrine cells and some RGCs; anti-PKCα labels rod bipolar cells and their dendrites as well as a subset of amacrine cells; anti-Ribeye labels ribbon synapses between bipolar cells and photoreceptors in the OPL, as well as synapses between amacrine cells and RGCs in the IPL; anti-calretinin labels three synaptic lamina within the IPL. There is no clear difference between WT and p58IPK −/− retina in labeling for any of these markers. All sections are counterstained with DAPI (blue) to label nuclei. n = 3 mice per group, scale bar = 50 μm. (B) Retinal whole mounts from WT and p58IPK −/− mice at 7 days after retinal I/R were stained with RGC marker, Tuj1. Representative images are shown on the left. Graph shows that the percentage of RGC loss, as determined from wholemount retinal Tuj1 staining, is significantly higher in p58IPK −/− mice compared to WT. Mean ± SD, n = 5 mice. *p < 0.05 (Student’s t-test). Scale bar = 100 μm. (C) Graph depicts the average intraocular pressure (IOP) of sham control eyes and microbead-injected eyes in WT (+/+) and p58IPK −/− mice at the time points as indicated. (D) Retinal whole mounts from WT and p58IPK −/− mice at 14 days after microbead injection were stained with RGC marker, Tuj1. Representative images are shown on the left. Bar graph shows the percentage of RGC loss is significantly greater in p58IPK −/− mice compared to WT. Mean ± SD, n = 4 mice. *p < 0.05 (Student’s t-test).

Loss of p58IPK exacerbates retinal ganglion cell (RGC) cell death in retinal ischemia/reperfusion (I/R) and microbead-induced ocular hypertension. (A) Retinal cryosections (20 μM) from 2-month-old wild type (WT) and p58IPK −/− mice labeled with primary antibodies against various retinal markers and a fluorescent secondary antibody (red). Anti-Pax6 labels amacrine cells and some RGCs; anti-PKCα labels rod bipolar cells and their dendrites as well as a subset of amacrine cells; anti-Ribeye labels ribbon synapses between bipolar cells and photoreceptors in the OPL, as well as synapses between amacrine cells and RGCs in the IPL; anti-calretinin labels three synaptic lamina within the IPL. There is no clear difference between WT and p58IPK −/− retina in labeling for any of these markers. All sections are counterstained with DAPI (blue) to label nuclei. n = 3 mice per group, scale bar = 50 μm. (B) Retinal whole mounts from WT and p58IPK −/− mice at 7 days after retinal I/R were stained with RGC marker, Tuj1. Representative images are shown on the left. Graph shows that the percentage of RGC loss, as determined from wholemount retinal Tuj1 staining, is significantly higher in p58IPK −/− mice compared to WT. Mean ± SD, n = 5 mice. *p < 0.05 (Student’s t-test). Scale bar = 100 μm. (C) Graph depicts the average intraocular pressure (IOP) of sham control eyes and microbead-injected eyes in WT (+/+) and p58IPK −/− mice at the time points as indicated. (D) Retinal whole mounts from WT and p58IPK −/− mice at 14 days after microbead injection were stained with RGC marker, Tuj1. Representative images are shown on the left. Bar graph shows the percentage of RGC loss is significantly greater in p58IPK −/− mice compared to WT. Mean ± SD, n = 4 mice. *p < 0.05 (Student’s t-test).

p58IPK Deficiency Exacerbates RGC Loss Induced by Retinal I/R

Retinal I/R is a widely used model for investigating the mechanisms and treatment of inner retinal neuron injury caused by acute ischemia. Seven days after I/R, RGC numbers were examined by immunostaining for Tuj1, a putative RGC marker, in retinal whole mounts. We found a 36.6% RGC loss in WT mice and a 52.0% RGC loss in p58IPK −/− mice (Figure 1B). This indicates that I/R induced a significantly higher rate of RGC loss (a 42% increase) in p58IPK −/− mice than in WT, suggesting a protective role of p58IPK in RGCs.

Loss of p58IPK Increases RGC Damage in Microbead-Induced Ocular Hypertension

We used a second model that is highly relevant to glaucoma to validate the role of p58IPK in RGC protection. We found no significant difference in IOP elevation after microbead injection in p58IPK −/− and WT mice (Figure 1C). Two weeks after induction, WT retinas with increased IOP exhibited a 20% loss of RGCs; the percentage of RGC loss increased significantly to over 35% in p58ipk −/− mice (Figure 1D). This again indicates that a loss of p58IPK results in an increase in RGC death.

Overexpression of p58IPK Protects RGCs From ER Stress-Induced Cell Death

Next, we examined whether overexpressing p58IPK by AAV is sufficient to protect primary mouse RGCs isolated from p58IPK −/− and WT mice. Under control conditions, we found that the percentage of RGCs survival in culture was significantly decreased in p58IPK −/− RGCs compared to WT (Figure 2A), although this decrease was not rescued by acute overexpression of p58IPK. TM exposure caused a significant loss of cells in both p58IPK −/− and WT RGCs infected with control virus (Figure 2A). Overexpressing p58IPK led to a significant recovery to near control levels of survivability in both WT and p58IPK −/− RGCs.
Figure 2

Overexpressing p58IPK by adeno-associated virus (AAV) protects RGCs from endoplasmic reticulum (ER) stress-induced cell death. (A) Cultured primary mouse RGCs isolated from p58IPK −/− and WT retinas were infected with AAV-GFP or AAV-p58IPK 24 h prior to a 16 h-treatment with tunicamycin (TM; 1 μg/ml) or control. Cells are labeled with the live/dead cytotoxicity assay (calcein-AM to label live cells (green) and ethidium homodimer-1 to label dead cells (red)). Representative images of live/dead assay are shown above. Graph depicts the survival percentage of RGCs from WT and p58IPK −/− mice. Under control conditions, p58IPK −/− RGCs infected with AAV-GFP have a significantly lower survival percentage than the matched WT group. RGCs from both WT and p58IPK −/− mice infected with AAV-GFP show a significant decrease in survival percentage after TM treatment compared to control treatment. The survival percentage is significantly increased for RGCs infected with AAV-p58IPK, compared to infection with AAV-GFP for both WT and p58IPK −/− mice. Mean ± SD, n = 3 independent experiments. *p < 0.05 (one-way ANOVA with Bonferroni post hoc test). Scale bar = 80 μm. (B) Quantitative RT-PCR (qPCR; top) using total RNA from whole retina from 2-month-old WT and p58IPK −/− mice. Two sets of independent primers specific for mesencephalic astrocyte-derived neurotrophic factor (MANF) reveal a mean significant 50% reduction in mRNA level in p58IPK −/− retina compared to WT. All qPCR data are normalized to 18 s. Mean ± SD, n = 3 mice per genotype. *p < 0.05 (Student’s t-test). Western blot analysis (bottom) of whole retina lysate from WT or p58IPK −/− mice reveal that the level of MANF protein is not statistically different for whole retina (n = 6 mice per group). (C) R28 cells in culture exposed to 16-h pre-treatment with 50 ng/ml MANF or vehicle, followed by 5 μg/ml TM or control treatment for 24 h. Cells are labeled with the live/dead cytotoxicity assay as in (A). Quantification of the survival of R28 cells reveals that approximately 60% of R28 cells survive TM treatment in the absence of MANF. With MANF pre-treatment the survival percentage is significantly increased to over 85%. Mean ± SD, n = 4 independent experiments; *p < 0.05, **p < 0.01 (one-way ANOVA with Bonferroni post hoc test). Scale bar = 100 μm.

Overexpressing p58IPK by adeno-associated virus (AAV) protects RGCs from endoplasmic reticulum (ER) stress-induced cell death. (A) Cultured primary mouse RGCs isolated from p58IPK −/− and WT retinas were infected with AAV-GFP or AAV-p58IPK 24 h prior to a 16 h-treatment with tunicamycin (TM; 1 μg/ml) or control. Cells are labeled with the live/dead cytotoxicity assay (calcein-AM to label live cells (green) and ethidium homodimer-1 to label dead cells (red)). Representative images of live/dead assay are shown above. Graph depicts the survival percentage of RGCs from WT and p58IPK −/− mice. Under control conditions, p58IPK −/− RGCs infected with AAV-GFP have a significantly lower survival percentage than the matched WT group. RGCs from both WT and p58IPK −/− mice infected with AAV-GFP show a significant decrease in survival percentage after TM treatment compared to control treatment. The survival percentage is significantly increased for RGCs infected with AAV-p58IPK, compared to infection with AAV-GFP for both WT and p58IPK −/− mice. Mean ± SD, n = 3 independent experiments. *p < 0.05 (one-way ANOVA with Bonferroni post hoc test). Scale bar = 80 μm. (B) Quantitative RT-PCR (qPCR; top) using total RNA from whole retina from 2-month-old WT and p58IPK −/− mice. Two sets of independent primers specific for mesencephalic astrocyte-derived neurotrophic factor (MANF) reveal a mean significant 50% reduction in mRNA level in p58IPK −/− retina compared to WT. All qPCR data are normalized to 18 s. Mean ± SD, n = 3 mice per genotype. *p < 0.05 (Student’s t-test). Western blot analysis (bottom) of whole retina lysate from WT or p58IPK −/− mice reveal that the level of MANF protein is not statistically different for whole retina (n = 6 mice per group). (C) R28 cells in culture exposed to 16-h pre-treatment with 50 ng/ml MANF or vehicle, followed by 5 μg/ml TM or control treatment for 24 h. Cells are labeled with the live/dead cytotoxicity assay as in (A). Quantification of the survival of R28 cells reveals that approximately 60% of R28 cells survive TM treatment in the absence of MANF. With MANF pre-treatment the survival percentage is significantly increased to over 85%. Mean ± SD, n = 4 independent experiments; *p < 0.05, **p < 0.01 (one-way ANOVA with Bonferroni post hoc test). Scale bar = 100 μm.

Reduced Retinal mRNA Expression of MANF in p58IPK −/− Mice

MANF is a member of a newly identified ER-localized neurotrophic factor family and is upregulated during ER stress (Glembotski et al., 2012). We investigated whether MANF expression is altered in p58IPK −/− retinas. Using qPCR, we found that MANF mRNA expression was significantly reduced in the retina of p58IPK −/− mice (Figure 2B). However, the protein level appeared to be insignificantly different (Figure 2B). To further explore whether there is a reciprocal regulation between p58IPK and MANF, we transduced R28 cells with adenovirus to overexpress p58IPK and then treated the cells with TM to induce ER stress. We found that both MANF and p58IPK levels were significantly increased after TM treatment (Supplementary Figure S1A). Overexpression of p58IPK did not alter MANF protein expression in unstimulated cells, but significantly reduced the induction of MANF by TM (Supplementary Figure S1A).

Recombinant MANF Protects R28 Cells or Retinal Explants From ER Stress Induced Cell Death and Caspase-3 Activation

To examine whether MANF is important for neuronal survival under ER stress, we pretreated R28 cells with 50 ng/ml recombinant hMANF protein or vehicle (0.1% PBS) followed by treatment with 5 μg/ml TM, or vehicle, for 24 h. We find TM treatment induces cell death in 43% of R28 cells in the absence of MANF treatment (Figure 2C). With MANF pretreatment, this number was reduced to 16%, which represents a recovery to 91% of the survival rate of control R28 cells treated with vehicle (Figure 2C). In addition, MANF treatment significantly reduced TM-elicited caspase-3 activation in ex vivo cultured retinal explants (Supplementary Figure S1B).

Discussion

The findings from the present study provide strong evidence for an endogenous role of p58IPK in protection of RGCs in conditions of ER stress, acute ischemia and ocular hypertension. Previous studies, including our own, have implicated p58IPK in a broad range of neurodegenerative diseases and diabetes (Ladiges et al., 2005; Boriushkin et al., 2014, 2015, 2016; Han et al., 2015; McLaughlin and Zhang, 2015). Clinically, patients bearing loss-of-function mutations in the DNAJC3 gene, which encodes p58IPK, suffer from diabetes and multisystemic neurodegeneration (Synofzik et al., 2014). In animal models, loss of p58IPK results in increased ER stress and oxidative stress, decreased β cell function, progressive cell death and diabetes in male p58IPK KO mice (Ladiges et al., 2005; Han et al., 2015). In contrast to the relatively thoroughly studied role of p58IPK in diabetes, how p58IPK regulates neuronal function remains unexplored. Herein, we examined the impact of p58IPK deficiency on RGC survival in disease-relevant models. Our data clearly indicate an important role of p58IPK in RGC survival during acute retinal ischemia and in ocular hypertension. Notably, we used young adult p58IPK KO mice that demonstrate no significant morphological defects in the retina compared to their age-matched littermate controls. In addition, most of our experiments were carried out in female mice at 2 months of age, which do not experience increased blood glucose levels as some male p58IPK KO mice do with age. Our in vitro results suggest a therapeutic potential of overexpressing p58IPK or enhancing its function for neuroprotection of RGCs, which warrants an in vivo study in disease models. Another interesting finding is that there is likely a reciprocal regulation between p58IPK and MANF in retinal cells undergoing ER stress. Recent studies show that MANF protects CNS neurons (Voutilainen et al., 2017) and markedly improves RGC survival in a rat glaucoma model (Gao et al., 2017). Our data support these findings and demonstrate that MANF inhibits ER stress-induced cell death and caspase-3 activation in retinal cells and explants. In R28 cells, both p58IPK and MANF are upregulated during ER stress; interestingly, overexpressing p58IPK reduces ER stress-stimulated MANF upregulation. This suggests a potential interaction between the two chaperones, which both bind to GRP78 and regulate the UPR, although it remains unclear whether MANF secretion is affected by p58IPK manipulation. Future studies will investigate how MANF and p58IPK are regulated in RGCs and whether overexpression of p58IPK and MANF would synergistically promote RGC survival and function.

Author Contributions

TM designed and performed the experiments, analyzed the data and drafted the manuscript. ND and JL performed the experiments, analyzed the data and revised the manuscript. JW and SZ conceived and designed the study, reviewed all the data, drafted and revised the manuscript. All authors read and approved the final manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  26 in total

1.  Activation of the UPR protects against cigarette smoke-induced RPE apoptosis through up-regulation of Nrf2.

Authors:  Chuangxin Huang; Joshua J Wang; Jacey H Ma; Chenjin Jin; Qiang Yu; Sarah X Zhang
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

2.  Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK.

Authors:  Warren C Ladiges; Sue E Knoblaugh; John F Morton; Marcus J Korth; Bryce L Sopher; Carole R Baskin; Alasdair MacAuley; Alan G Goodman; Renee C LeBoeuf; Michael G Katze
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

3.  Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse.

Authors:  Huihui Chen; Xin Wei; Kin-Sang Cho; Guochun Chen; Rebecca Sappington; David J Calkins; Dong F Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

4.  Identification of p58IPK as a novel neuroprotective factor for retinal neurons.

Authors:  Evgenii Boriushkin; Joshua J Wang; Junhua Li; Guangjun Jing; Gail M Seigel; Sarah X Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-05       Impact factor: 4.799

5.  Endoplasmic reticulum stress is sufficient for the induction of IL-1β production via activation of the NF-κB and inflammasome pathways.

Authors:  Sena Kim; Yeonsoo Joe; Sun Oh Jeong; Min Zheng; Sung Hoon Back; Sang Won Park; Stefan W Ryter; Hun Taeg Chung
Journal:  Innate Immun       Date:  2013-11-11       Impact factor: 2.680

6.  p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose.

Authors:  Anne-Laure Huber; Justine Lebeau; Patricia Guillaumot; Virginie Pétrilli; Mouhannad Malek; Julien Chilloux; Frédérique Fauvet; Léa Payen; Alain Kfoury; Toufic Renno; Eric Chevet; Serge N Manié
Journal:  Mol Cell       Date:  2013-02-07       Impact factor: 17.970

Review 7.  ER stress and apoptosis: a new mechanism for retinal cell death.

Authors:  Guangjun Jing; Joshua J Wang; Sarah X Zhang
Journal:  Exp Diabetes Res       Date:  2011-12-14

8.  Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes.

Authors:  Yimin Zhong; Jingming Li; Yanming Chen; Joshua J Wang; Rajiv Ratan; Sarah X Zhang
Journal:  Diabetes       Date:  2012-01-06       Impact factor: 9.461

9.  The neuroprotective potential of endoplasmic reticulum chaperones.

Authors:  Todd McLaughlin; Sarah X Zhang
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

10.  Identification of Mesencephalic Astrocyte-Derived Neurotrophic Factor as a Novel Neuroprotective Factor for Retinal Ganglion Cells.

Authors:  Feng-Juan Gao; Ji-Hong Wu; Ting-Ting Li; Shan-Shan Du; Qiang Wu
Journal:  Front Mol Neurosci       Date:  2017-03-17       Impact factor: 5.639

View more
  5 in total

Review 1.  Potential Role of MANF, an ER Stress Responsive Neurotrophic Factor, in Protecting Against Alcohol Neurotoxicity.

Authors:  Wen Wen; Hui Li; Jia Luo
Journal:  Mol Neurobiol       Date:  2022-03-07       Impact factor: 5.590

2.  Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury.

Authors:  Abdelrahman Y Fouda; Wael Eldahshan; Zhimin Xu; Tahira Lemtalsi; Esraa Shosha; Syed Ah Zaidi; Ammar A Abdelrahman; Paul Ning-Man Cheng; S Priya Narayanan; R William Caldwell; Ruth B Caldwell
Journal:  Exp Neurol       Date:  2021-11-12       Impact factor: 5.620

Review 3.  Retinal Glutamate Neurotransmission: From Physiology to Pathophysiological Mechanisms of Retinal Ganglion Cell Degeneration.

Authors:  Isabella Boccuni; Richard Fairless
Journal:  Life (Basel)       Date:  2022-04-25

Review 4.  Endoplasmic reticulum stress: New insights into the pathogenesis and treatment of retinal degenerative diseases.

Authors:  Marina S Gorbatyuk; Christopher R Starr; Oleg S Gorbatyuk
Journal:  Prog Retin Eye Res       Date:  2020-04-06       Impact factor: 21.198

Review 5.  Cellular stress signaling and the unfolded protein response in retinal degeneration: mechanisms and therapeutic implications.

Authors:  Todd McLaughlin; Andy Medina; Jacob Perkins; Maria Yera; Joshua J Wang; Sarah X Zhang
Journal:  Mol Neurodegener       Date:  2022-03-28       Impact factor: 14.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.